PDF herunterladen
CC BY-NC-ND 4.0 · Journal of Morphological Sciences 2019; 36(01): 002-006
DOI: 10.1055/s-0039-1681110
Original Article
Thieme Revinter Publicações Ltda Rio de Janeiro, Brazil

Effects of Supraphysiological Doses of Anabolic Androgenic Steroids on the Left Ventricles of Male and Female Mice Submitted to Swimming

Laís Cristina Teodoro Jerônimo
1   Universidade Federal de Alfenas, Alfenas, MG, Brazil
,
Priscila Franco
1   Universidade Federal de Alfenas, Alfenas, MG, Brazil
,
Petrus Pires Marques
2   Departament of Morphology, Universidade José Vellano, Alfenas, MG, Brazil
,
Flávia da Ré Guerra
3   Department of Anatomy, Universidade Federal de Alfenas, Alfenas, MG, Brazil
,
Wagner Costa Rossi Junior
3   Department of Anatomy, Universidade Federal de Alfenas, Alfenas, MG, Brazil
,
Alessandra Esteves
3   Department of Anatomy, Universidade Federal de Alfenas, Alfenas, MG, Brazil
› Institutsangaben
Weitere Informationen

Publikationsverlauf

22. August 2018

28. Januar 2019

Publikationsdatum:
01. März 2019 (online)

   Lizenzen und Reprints

Abstract

The use of anabolic androgenic steroids (AAS) has grown into a worldwide substance abuse problem over the last decades, with the doses taken by illegal users being 10 to 100 times higher than the therapeutic ones. In the present experiment, 60 mice were divided into 3 groups of 20 animals. Group 1 received testosterone cypionate (Deposteron [EMS, São Bernardo do Campo, SP, Brazil]); group 2 received stanozolol (Stanozolol Depot, Landerlan, Lambaré, Paraguay), and group 3 received saline solution), each one composed by 10 males and 10 females, treated once a week and put to swimming thrice a week for 2 months. After euthanasia, their chests were opened, the hearts removed and processed histologically for morphometric analyses. The specimens were cut into 6 different sections and each one was measured with the help of an optical microscope with a 40-fold magnification. For such analyses, the Axiovision Rel. 4.8.2 (Carl Zeiss Microscopy LLC, Peabody, MA, USA) and Axiovision 4 Module Interactive Measurement (Carl Zeiss Microscopy LLC) software were used. The results showed that there was an increase in the diameter of the left ventricles in the male mice treated with Deposteron while in the female animals treated with Winstrol, there was a decrease in the left ventricular diameter in relation to the other two groups. Thus, one can conclude that the use of supraphysiological doses of the given AAS significantly alters the ventricular diameter in both male and female animals, which can cause a considerable change in both heart rate and blood pressure, and potentially induce disorders that are very relevant to the organism.

Keywords

anabolic steroids - left ventricle - mice - morphometric analysis

Financial Support

Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG, in the Portuguese acronym)/UNIFAL-MG


 

  • References

  • 1 Kanayama G, Pope Jr HG. History and epidemiology of anabolic androgens in athletes and non-athletes. Mol Cell Endocrinol 2018; 464: 4-13
    CrossrefPubMedSuche in Google Scholar
  • 2 Parent MC, Bradstreet TC. Sexual orientation, bullying for being labeled gay or bisexual, and steroid use among US adolescent boys. J Health Psychol 2018; 23 (04) 608-617 . Doi: 10.1177/1359105317692144
    CrossrefPubMedSuche in Google Scholar
  • 3 Smurawa TM, Congeni JA. Testosterone precursors: use and abuse in pediatric athletes. Pediatr Clin North Am 2007; 54 (04) 787-796, xii . Doi: 10.1016/j.pcl.2007.05.002
    CrossrefPubMedSuche in Google Scholar
  • 4 Nieschlag E, Vorona E. Doping with anabolic androgenic steroids (AAS): Adverse effects on non-reproductive organs and functions. Rev Endocr Metab Disord 2015; 16 (03) 199-211 . Doi: 10.1007/s11154-015-9320-5
    CrossrefPubMedSuche in Google Scholar
  • 5 Marqueti RC, Paulino MG, Fernandes MN, de Oliveira EM, Selistre-de-Araujo HS. Tendon structural adaptations to load exercise are inhibited by anabolic androgenic steroids. Scand J Med Sci Sports 2014; 24 (01) e39-e51 . Doi: 10.1111/sms.12135
    CrossrefPubMedSuche in Google Scholar
  • 6 Kam PC, Yarrow M. Anabolic steroid abuse: physiological and anaesthetic considerations. Anaesthesia 2005; 60 (07) 685-692 . Doi: 10.1111/j.1365-2044.2005.04218.x
    CrossrefPubMedSuche in Google Scholar
  • 7 Krieg A, Scharhag J, Albers T, Kindermann W, Urhausen A. Cardiac tissue Doppler in steroid users. Int J Sports Med 2007; 28 (08) 638-643 . Doi: 10.1055/s-2007-964848
    Thieme ConnectPubMedSuche in Google Scholar
  • 8 Urhausen A, Albers T, Kindermann W. Are the cardiac effects of anabolic steroid abuse in strength athletes reversible?. Heart 2004; 90 (05) 496-501 . Doi: 10.1136/hrt.2003.015719
    CrossrefPubMedSuche in Google Scholar
  • 9 Alves DM, Silva MSO, Zavan B. , et al. Morphometric analysis of mice's ventricular myocardium submitted to androgenic anabolizing steroids use. Journal of morphological. Science 2015; 32 (01) 33-36 . Doi: 10.4322/jms.071614
    PubMedSuche in Google Scholar
  • 10 Tostes RC, Carneiro FS, Carvalho MH, Reckelhoff JF. Reactive oxygen species: players in the cardiovascular effects of testosterone. Am J Physiol Regul Integr Comp Physiol 2016; 310 (01) R1-R14 . Doi: 10.1152/ajpregu.00392.2014
    CrossrefPubMedSuche in Google Scholar
  • 11 Hayward CS, Kelly RP, Collins P. The roles of gender, the menopause and hormone replacement on cardiovascular function. Cardiovasc Res 2000; 46 (01) 28-49
    CrossrefPubMedSuche in Google Scholar
  • 12 D'Andrea A, Caso P, Salerno G. , et al. Left ventricular early myocardial dysfunction after chronic misuse of anabolic androgenic steroids: a Doppler myocardial and strain imaging analysis. Br J Sports Med 2007; 41 (03) 149-155 . Doi: 10.1136/bjsm.2006.03017
    CrossrefPubMedSuche in Google Scholar
  • 13 Kasikcioglu E, Oflaz H, Umman B, Bugra Z. Androgenic anabolic steroids also impair right ventricular function. Int J Cardiol 2009; 134 (01) 123-125 . Doi: 10.1016/j.ijcard.2007.12.027
    CrossrefPubMedSuche in Google Scholar
  • 14 Thiblin I, Lindquist O, Rajs J. Cause and manner of death among users of anabolic androgenic steroids. J Forensic Sci 2000; 45 (01) 16-23
    PubMedSuche in Google Scholar
  • 15 Barbosa Neto O, da Mota GR, De Sordi CC. , et al. Long-term anabolic steroids in male bodybuilders induce cardiovascular structural and autonomic abnormalities. Clin Auton Res 2018; 28 (02) 231-244
    CrossrefPubMedSuche in Google Scholar
  • 16 Pirompol P, Teekabut V, Weerachatyanukul W, Bupha-Intr T, Wattanapermpool J. Supra-physiological dose of testosterone induces pathological cardiac hypertrophy. J Endocrinol 2016; 229 (01) 13-23
    CrossrefPubMedSuche in Google Scholar
  • 17 Christakou CD, Diamanti-Kandarakis E. Role of androgen excess on metabolic aberrations and cardiovascular risk in women with polycystic ovary syndrome. Womens Health (Lond) 2008; 4 (06) 583-594 . Doi: 10.2217/17455057.4.6.583
    CrossrefPubMedSuche in Google Scholar
  • 18 Cho MH, Jung KJ, Jang HS, Kim JI, Park KM. Orchiectomy attenuates kidney fibrosis after ureteral obstruction by reduction of oxidative stress in mice. Am J Nephrol 2012; 35 (01) 7-16 . Doi: 10.1159/000334598
    CrossrefPubMedSuche in Google Scholar
  • 19 Elnakish MT, Hassanain HH, Janssen PM, Angelos MG, Khan M. Emerging role of oxidative stress in metabolic syndrome and cardiovascular diseases: important role of Rac/NADPH oxidase. J Pathol 2013; 231 (03) 290-300 . Doi: 10.1002/path.4255
    CrossrefPubMedSuche in Google Scholar
  • 20 Frati P, Busardò FP, Cipolloni L, Dominicis ED, Fineschi V. Anabolic Androgenic Steroid (AAS) related deaths: autoptic, histopathological and toxicological findings. Curr Neuropharmacol 2015; 13 (01) 146-159 . Doi: 10.1152/ajpregu.00392.2014
    CrossrefPubMedSuche in Google Scholar
  • 21 Ellis JA, Infantino T, Harrap SB. Sex-dependent association of blood pressure with oestrogen receptor genes ERalpha and ERbeta. J Hypertens 2004; 22 (06) 1127-1131
    CrossrefPubMedSuche in Google Scholar
  • 22 Pedrosa DF, de Rezende LCD, Silva VI, Rangel LBA, Gonçalves WLS, Graceli JB. Efeitos benéficos do estrogênio no Sistema Cardiovascular. Revista Cientifica Perspectivas On Line. 2009; 3 (12) 190-196
    PubMedSuche in Google Scholar
  • 23 Apaijai N, Charoenphandhu N, Ittichaichareon J. , et al. Estrogen deprivation aggravates cardiac hypertrophy in nonobese Type 2 diabetic Goto-Kakizaki (GK) rats. Biosci Rep 2017; 37 (05) 1-10 . Doi: 10.1042/BSR20170886
    PubMedSuche in Google Scholar
  • 24 Montisci M, El Mazloum R, Cecchetto G. , et al. Anabolic androgenic steroids abuse and cardiac death in athletes: morphological and toxicological findings in four fatal cases. Forensic Sci Int 2012; 217 (1-3): e13-e18 . Doi: 10.1016/j.forsciint.2011.10.032
    CrossrefPubMedSuche in Google Scholar
  • 25 Soares MCR, Abreu IC, Assenco F, Borges MOR. Decanoato de nandrolona Aumenta a Parede Ventricular Esquerda, mas Atenua o Aumento da Cavidade Provocado Pelo Treinamento de Natação em Ratos. Rev Bras Med Esporte 2011; 17 (06) 420-424 . Doi: 10.1530/JOE-15-0506
    PubMedSuche in Google Scholar
  • 26 Hayward CS, Webb CM, Collins P. Effect of sex hormones on cardiac mass. Lancet 2001; 357 (9265): 1354-1356 . Doi: 10.1016/S0140-6736(00)04523-2
    CrossrefPubMedSuche in Google Scholar
  • 27 Dickerman RD, Schaller F, McConathy WJ. Left ventricular wall thickening does occur in elite power athletes with or without anabolic steroid Use. Cardiology 1998; 90 (02) 145-148
    CrossrefPubMedSuche in Google Scholar
  • 28 Mewis C, Spyridopoulos I, Kühlkamp V, Seipel L. Manifestation of severe coronary heart disease after anabolic drug abuse. Clin Cardiol 1996; 19 (02) 153-155 . Doi: 10.1002/clc.4960190216
    CrossrefPubMedSuche in Google Scholar
  • 29 Codd MB, Sugrue DD, Gersh BJ, Melton III LJ. Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984. Circulation 1989; 80 (03) 564-572
    CrossrefPubMedSuche in Google Scholar
  • 30 Albanesi Filho F. Cardiomiopatias. Arq Bras Cardiol 1998; 71 (02) 95-107
    PubMedSuche in Google Scholar
  • 31 Cecchi R, Muciaccia B, Ciallella C. , et al. Ventricular androgenic-anabolic steroid-related remodeling: an immunohistochemical study. Int J Legal Med 2017; 131 (06) 1589-1595 . Doi: 10.1007/s00414-017-1589-3
    CrossrefPubMedSuche in Google Scholar
  • 32 Sinha-Hikim I, Artaza J, Woodhouse L. , et al. Testosterone-induced increase in muscle size in healthy young men is associated with muscle fiber hypertrophy. Am J Physiol Endocrinol Metab 2002; 283 (01) E154-E164
    CrossrefPubMedSuche in Google Scholar
  • 33 Zaugg M, Jamali NZ, Lucchinetti E. , et al. Anabolic-androgenic steroids induce apoptotic cell death in adult rat ventricular myocytes. J Cell Physiol 2001; 187 (01) 90-95 . Doi: 10.1002/1097-4652(2001)9999:9999<00:AIDJCP1057>3.0.CO;2-Y
    CrossrefPubMedSuche in Google Scholar